Therapeutic effect of antisecretory factor-rich egg yolk on the late phases of 2,4,6-trinitrobenzenesulphonic acid colitis in mice

British Journal of Nutrition

Volumn 106, Issue 10, 2011, Pages 1522-1528

  Mañé, Josep ^a,b   Lorén, Violeta ^a,b   Pedrosa, Elisabet ^a,b   Ojanguren, Isabel ^c   Domènech, Eugeni ^b,c   Gassull, Miquel A ^a   Cabré, Eduard ^b,c  

^a Germans Trias i Pujol Research Institute in Health Sciences   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Antisecretory factor; Apoptosis; Cytokines; Eicosanoids; Trinitrobenzenesulphonic acid

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTISECRETORY FACTOR; DRINKING WATER; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LEUKOTRIENE B4; MYELOPEROXIDASE; PARAFFIN; PROSTAGLANDIN E2; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTISECRETORY FACTOR RICH EGG YOLK; APOPTOSIS; ARTICLE; COLITIS; COLON; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; EGG YOLK; ENZYME ACTIVITY; EPITHELIUM CELL; EXPLANT; FEMALE; FREEZE DRYING; HISTOLOGY; LAMINA PROPRIA; LYMPHOCYTE; MOUSE; NONHUMAN; PROSTAGLANDIN RELEASE;

ANIMALS; COLITIS; EGG YOLK; FEMALE; MICE; MICE, INBRED BALB C; NEUROPEPTIDES; TRINITROBENZENESULFONIC ACID;

MAMMALIA; MUS;

EID: 80755169035     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511002042     Document Type: Article

References (40)

1. Johansson E, Lönnroth I, Lange S, et al. (1995) Molecular cloning and expression of pituitary gland protein modulating intestinal fluid secretion. J Biol Chem 270, 20615-20620.
2. Johansson E, Jennische E, Lange S, et al. (1997) Antisecretory factor suppresses intestinal inflammation and hypersecretion. Gut 41, 642-645.
3. Kim M, Wasling P, Xiao MY, et al. (2005) Antisecretory factor modulates GABAergic transmission in the rat hippocampus. Regul Pept 129, 109-118. (Pubitemid 40775793)
4. Davidson TS & Hickey WF (2004) Distribution and immunoregulatory properties of antisecretory factor. Lab Invest 84, 307-319. (Pubitemid 41656486)
5. Björck S, Bosaeus I, Ek E, et al. (2000) Food induced stimulation of the antisecretory factor can improve symptoms in human inflammatory bowel disease: a study of a concept. Gut 46, 824-829. (Pubitemid 30329078)
6. Laurenius A, Wangberg B, Lange E, et al. (2003) Antisecretory factor counteracts secretory diarrhoea of endocrine origin. Clin Nutr 22, 549-552. (Pubitemid 37455722)
7. Lange S, Bosaeus I, Jennische E, et al. (2003) Food-induced antisecretory factor activity is correlated with small bowel length in patients with intestinal resections. APMIS 111, 985-988. (Pubitemid 37352618)
8. Lange S, Lönnroth I & Martinsson K (1994) Concentrations of antisecretory factor in eggs and in chicken blood plasma. Br Poult Sci 35, 615-620.
9. Eriksson A, Shafazand M, Jennische E, et al. (2003) Effect of antisecretory factor in ulcerative colitis on histological and laborative outcome: a short period clinical trial. Scand J Gastroenterol 38, 1045-1049. (Pubitemid 37352467)
10. Eriksson A, Shafazand M, Jennische E, et al. (2003) Antisecretory factor-induced regression of Crohn's disease in a weak responder to conventional pharmacological treatment. Inflamm Bowel Dis 9, 398-400. (Pubitemid 37461453)
11. Neurath M, Fuss I & Strober W (2000) TNBS-colitis. Int Rev Immunol 19, 51-62. (Pubitemid 30146942)
12. Morris GP, Beck PL, Herridge MS, et al. (1989) Hapteninduced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 93, 795-803. (Pubitemid 19057602)
13. Sturm A & Fiocchi C (2002) Life and death in the gut: more killing, less Crohn's. Gut 50, 148-149. (Pubitemid 34087922)
14. Santaolalla R, Mañé J, Pedrosa E, et al. (2011) Apoptosis resistance of mucosal lymphocytes and IL-10 deficiency in patients with steroid-refractory Crohn's disease. Inflamm Bowel Dis 17, 1490-1500.
15. Mañé J, Pedrosa E, Lorén V, et al. (2009) Partial replacement of dietary (n-6) fatty acids with medium-chain triglycerides decreases the incidence of spontaneous colitis in interleukin-10-deficient mice. J Nutr 139, 602-610.
16. Newmark HL (1987) Nutrient density: an important and useful tool for laboratory animal studies. Carcinogenesis 8, 871-873. (Pubitemid 17133573)
17. Mañé J, Lorén V, Pedrosa E, et al. (2009) Lactobacillus fermentum CECT 5716 prevents and reverts intestinal damage on TNBS-induced colitis in mice. Inflamm Bowel Dis 15, 1155-1163.
18. Zamuner SR, Warrier N, Buret AG, et al. (2003) Cyclooxygenase 2 mediates post-inflammatory colonic secretory and barrier dysfunction. Gut 52, 1714-1720. (Pubitemid 37521248)
19. Narumiya S (2003) Prostanoids in immunity: roles revealed by mice deficient in their receptors. Life Sci 74, 391-395. (Pubitemid 37357068)
20. Fukata M, Chen A, Klepper A, et al. (2006) Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: role in proliferation and apoptosis in the intestine. Gastroenterology 131, 862-877. (Pubitemid 44316821)
21. Ohara K, Kono T, Chisato N, et al. (2003) Acetic acid-derived prostaglandin-dependent colonic adaptive cytoprotection is preserved in chronic colitis: role of cyclo-oxygenase. Int J Colorectal Dis 18, 260-266. (Pubitemid 36764174)
22. Betz M & Fox BS (1991) Prostaglandin E2 inhibits production of Th-1 lymphokines but not of Th-2 lymphokines. J Immunol 146, 108-113.
23. Yokomizo T, Kato K, Terawaki K, et al. (2000) A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. J Exp Med 192, 421-432.
24. Tager AM, Bromley SK, Medoff BD, et al. (2003) Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nat Immunol 4, 982-990. (Pubitemid 37265919)
25. ten Hove T, van den Blink B, Pronk I, et al. (2002) Dichotomal role of inhibition of p38 MAKP with SB 203580 in experimental colitis. Gut 50, 507-512. (Pubitemid 34638870)
26. Dohi T, Fujihashi K, Kiyono H, et al. (2000) Mice deficient in Th1-and Th2-type cytokines develop distinct forms of hapten-induced colitis. Gastroenterology 119, 724-733.
27. Dohi T, Fujihashi K, Rennert PD, et al. (1999) Hapteninduced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses. J Exp Med 189, 1169-1179. (Pubitemid 29198256)
28. Musch E, Andus T, Kruis W, et al. (2005) Interferon-beta-1a for the treatment of steroid-refractory ulcerative colitis: a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 3, 581-586. (Pubitemid 40824751)
29. Pena-Rossi C, Schreiber S, Golubovic G, et al. (2008) Clinical trial: a multicentre, randomized, double-blind, placebocontrolled, dose-finding, phase II study of subcutaneous interferon-beta-la in moderately active ulcerative colitis. Aliment Pharmacol Ther 28, 758-767.
30. Gurtner GJ, Newberry RD, Schloemann SR, et al. (2003) Inhibition of indoleamine 2,3-dioxygenase augments trinitrobenzene sulfonic acid in mice. Gastroenterology 125, 1762-1773. (Pubitemid 37500441)
31. Lee GK, Park HJ, Macleod M, et al. (2002) Tryptophan deprivation sensitizes activated T cells to apoptosis prior T cell division. Immunology 107, 452-460. (Pubitemid 36693650)
32. Fallarino F, Grohmann U, Vacca C, et al. (2002) T cell apoptosis by tryptophan catabolism. Cell Death Differ 9, 1069-1077.
33. Lügering A, Lebiedz P, Koch S, et al. (2006) Apoptosis as a therapeutic tool in IBD? Ann N Y Acad Sci 1072, 62-77. (Pubitemid 44448444)
34. Roselli M, Finamore A, Nuccitelli S, et al. (2009) Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of gammadeltaT and regulatory T cells of intestinal intraepithelial lymphocytes. Inflamm Bowel Dis 15, 1526-1536.
35. Sokol H, Pigneur B, Watterlot L, et al. (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 105, 16731-16736.
36. Gao D, Wagner AH, Fankhaenel S, et al. (2005) CD40 antisense oligonucleotide inhibition of trinitrobenzene sulphonic acid induced rat colitis. Gut 54, 70-77. (Pubitemid 40007220)
37. Caruso R, Sarra M, Stolfi C, et al. (2009) Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut. Gastroenterology 136, 2270-2279.
38. Neurath MF, Fuss I, Kelsall BL, et al. (1996) Experimental granulomatous colitis in mice is abrogated by induction of TGF-b-mediated oral tolerance. J Exp Med 183, 2605-2616. (Pubitemid 26192369)
39. Zingarelli B, Szabó C & Salzman AL (1999) Reduced oxidative and nitrosative damage in murine experimental colitis in absence of inducible nitric oxide synthase. Gut 45, 199-209. (Pubitemid 29333768)
40. Rachmilewitz D, Stamler JS, Karmeli F, et al. (1993) Peroxynitrite- induced rat colitis-a new model of colonic inflammation. Gastroenterology 105, 1681-1688. (Pubitemid 24002783)